Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $587.0500 (0.18%) ($587.0500 - $588.3500) on Mon. Jul. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.01% (three month average) | RSI | 47 | Latest Price | $587.0500(0.18%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -1.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) DIA(37%) IWD(34%) SPLV(33%) SPY(33%) | Factors Impacting REGN price | REGN will decline at least -1.005% in a week (0% probabilities). TBT(-10%) VIXM(-9%) UUP(-5%) VXX(-1%) SHY(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.005% (StdDev 2.01%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $598.75 | 5 Day Moving Average | $591.12(-0.69%) | 10 Day Moving Average | $595.86(-1.48%) | 20 Day Moving Average | $598.75(-1.95%) | To recent high | -15.2% | To recent low | 7.2% | Market Cap | $62.244b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |